<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320679">
  <stage>Registered</stage>
  <submitdate>6/10/2009</submitdate>
  <approvaldate>9/10/2009</approvaldate>
  <actrnumber>ACTRN12609000883213</actrnumber>
  <trial_identification>
    <studytitle>Prospective observational longitudinal registry of patients with stable coronary artery disease</studytitle>
    <scientifictitle>Prospective observational longitudinal registry of patients with stable coronary artery disease</scientifictitle>
    <utrn />
    <trialacronym>CLARIFY</trialacronym>
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Coronary Artery Disease</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Observation of standard management of coronary artery disease patients over a 5 year period.  Observations will be recorded at baseline and then every 12 months for 5 years.  Data will be recorded detailing; patient demographics, cardiovascular risk factors, medical history, physical status (height, weight, electrocardiogram, blood test results for lipids and glucose) and current medications.</interventions>
    <comparator>No treatment</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To characterise contemporary coronary artery disease (CAD) patients in terms of; demographic characteristics, clinical profiles and management and outcomes to identify gaps between treatment and evidence</outcome>
      <timepoint>5 years after recruitment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To determine the long term prognostic determinants in this population, including resting heart rate (measured using an electrcardiogram), with a view to developing a risk prediction model.  A statistic regression model will be used to determine the factors with prognostic importance.</outcome>
      <timepoint>5 years after recruitment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Outpatients with stable coronary artery disease proven by history of at least one of the following criteria:
- documented myocardial infarction (&gt;3months ago)
- coronary angiography showing at least one coronary stenosis of more than 50%
- chest pain with myocardial ischaemia proven by stress electrocardiogram, stress echocardiography or myocardial imaging
- coronary artery bypass graft or percutaneous coronary intervention (&gt;3 months ago)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- Patients hospitalised for cardiovascular disease within last 3 months (including revascularisation)
- Patients with planned revascularisation
- Conditions hampering participation in the 5 year follow up, such as limited cooperation, limited legal capacity, serious non-cardiovascular disease or conditions interfering with life expectancy (cancer, drug abuse etc) or severe cardiovascular disease (advanced heart failure, severe valve disease, history of valve repair/replacement etc)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/12/2009</anticipatedstartdate>
    <actualstartdate>18/02/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate>28/06/2010</actualenddate>
    <samplesize>30000</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,QLD,SA,WA,VIC</recruitmentstate>
    <countryoutsideaustralia>
      <country>France</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Greece</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ireland</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Portugal</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Bulgaria</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czech Republic</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Latvia</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Romania</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Russian Federation</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Slovakia</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Slovenia</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States of America</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Argentina</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Saudi Arabia</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>South Africa</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>China</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Korea, Democratic People's Republic Of</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Malaysia</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Thailand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Philippe Gabriel Steg</primarysponsorname>
    <primarysponsoraddress>Depatement de Cardiologie
Centre Hospitalier Bichat-Claude Bernard
46 rue Henri-Huchard
75018 Paris</primarysponsoraddress>
    <primarysponsorcountry>France</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Servier Laboratories Australia Pty Ltd</fundingname>
      <fundingaddress>8 Cato Street
Hawthorn Vic 3122</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Kim Fox</sponsorname>
      <sponsoraddress>Imperial College London, 
South Kensington Campus, 
London SW7 2AZ</sponsoraddress>
      <sponsorcountry>United Kingdom</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Roberto Ferrari</sponsorname>
      <sponsoraddress>Sant'Anna University Hospital of Ferrara, C.so Giovecca 203, 44100, 
Ferrara</sponsoraddress>
      <sponsorcountry>Italy</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Ian Ford</sponsorname>
      <sponsoraddress>e-Science Hub
Kelvin Building
Glasgow G12 8QQ</sponsoraddress>
      <sponsorcountry>United Kingdom</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Michael Tendera</sponsorname>
      <sponsoraddress>Cardiology Division, 
Medical University of Silesia,
Katowice</sponsoraddress>
      <sponsorcountry>Poland</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Jean Claude Tardif</sponsorname>
      <sponsoraddress>Montreal Heart Institute
5000, Belanger Street 
Montreal, Quebec  H1T 1C8</sponsoraddress>
      <sponsorcountry>Canada</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Assoc/Prof Chris Reid</othercollaboratorname>
      <othercollaboratoraddress>Faculty of Medicine Nursing and Health Sciences
3rd Floor, Burnet Building, AMREP
89 Commercial Rd
Melbourne Vic 3004</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>CLARIFY is an international, observational, longitudianl registry in stable coronary artery disease outpatients with 5 year follow up.  The registry will improve knowledge surrounding the care of outpatients with coronary artery disease.</summary>
    <trialwebsite>www.clarify-registry.com</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bellberry Ltd</ethicname>
      <ethicaddress>229 Greenhill Rd
Dulwich SA 5065</ethicaddress>
      <ethicapprovaldate>30/11/2009</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>28/10/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Louise Shiel</name>
      <address>Monash University
Caulfield Hospital
Grd Floor, Fethers Block
260 Kooyong Rd
Caulfield VIC 3162</address>
      <phone>+61 3 9076 6169</phone>
      <fax />
      <email>louise.shiel@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Louise Shiel</name>
      <address>Monash University
Caulfield Hospital
Grd Floor, Fethers Block
260 Kooyong Rd
Caulfield VIC 3162</address>
      <phone>+61 3 9076 6169</phone>
      <fax />
      <email>louise.shiel@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Claire Morgan</name>
      <address>Servier Laboratories
8 Cato St
Hawthorn VIC 3122</address>
      <phone>+61 3 8823 7236</phone>
      <fax />
      <email>claire.morgan@au.netgrs.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Chris Reid</name>
      <address>The Alfred Centre
6th Floor, 99 Commercial Road
Melbourne VIC 3004
Australia
</address>
      <phone>+ 61 3 9903 0050</phone>
      <fax />
      <email>chris.reid@monash.edu</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>